FOSTAMATINIB
FOSTAMATINIB is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including TAVALISSE. Available dosage form: tablet.
Drug Details
- Generic Name
- FOSTAMATINIB
- Brand Names
- TAVALISSE
- Application Number
- NDA209299
- Sponsor
- Rigel Pharmaceuticals, Inc.
- NDC Codes
- 2
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- FOSTAMATINIB
Indications and Usage
1 INDICATIONS AND USAGE TAVALISSE is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. TAVALISSE is a kinase inhibitor indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.